EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Advanced Lung Cancer Inflammation Index as Predictor of All-Cause Mortality in ST-Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention

Giancarlo Trimarchi iD, Fausto Pizzino iD, Alessio Lilli iD, Alberto Ranieri De Caterina, Augusto Esposito iD, Stefano Dalmiani iD, Annamaria Mazzone iD, Gianluca Di Bella, Sergio Berti iD, Umberto Paradossi iD

Journal of Clinical Medicine · 11.10.2024 · 13 (20) · 6059

DOI: 10.3390/jcm13206059 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 11.10.2024. Verfasst von Giancarlo Trimarchi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Medicine, University of Messina, 98100 Messina, Italy. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The advanced lung cancer inflammation index (ALI) is an independent prognostic biomarker used to assess inflammation and nutritional status in various cancers, heart failure, and acute coronary syndromes. This study investigates the prognostic significance of ALI in patients experiencing ST-elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (pPCI), comparing its predictive abilities with the established Neutrophil-Lymphocyte Ratio (NLR).

Methods

We conducted a retrospective analysis of 1171 patients from the Matrix Registry, encompassing demographic and clinical data for STEMI cases treated with pPCI, and ALI was determined using the formula [serum albumin (g/dL) × body mass index (kg/m2)]/NLR at the time of hospital admission. The primary outcome was all-cause mortality.

Results

Of the 1171 patients, 86 died during the follow-up period. Univariate analysis identified age, female gender, smoking, hypertension, diabetes, prior myocardial infarction (PMI), lower left ventricular ejection fraction (LVEF), and reduced ALI as factors associated with mortality. Multivariate analysis confirmed age (HR: 1.1, 95% CI: 1.05–1.11, p < 0.001) and PMI (HR: 2.4, 95% CI: 1.4–4.3, p = 0.001) as prominent independent predictors, alongside ALI (HR: 0.95, 95% CI: 0.92–0.97, p < 0.001) and LVEF (HR: 0.98, 95% CI: 0.97–0.99, p = 0.04). An ALI cut-off of ≤10 indicated a higher mortality risk (HR: 2.3, 95% CI: 1.5–3.7, p < 0.001). The area under the curve for ALI (0.732) surpassed that for NLR (0.685), demonstrating ALI’s superior predictive capability.

Conclusions

ALI is an independent prognostic factor for all-cause mortality in STEMI patients undergoing pPCI, showing greater discriminatory power than NLR, particularly in patients with ALI values ≤ 10, who face a 2.3-fold higher mortality risk.

Schlagwörter

Stichwörter der Autor:innen

ST-elevation myocardial infarctioninflammationmalnutritionmortalityneutrophil-to-lymphocyte ratioprimary PCIvanced lung cancer inflammation index

Autor:innen und Institutionen

  • Department of Clinical and Experimental Medicine, University of Messina, 98100 Messina, Italy.
  • Interdisciplinary Center for Health Sciences, Scuola Superiore Sant'Anna, 56127 Pisa, Italy.
  • Cardiology Unit, Heart Centre, Fondazione Gabriele Monasterio-Regione Toscana, 54100 Massa, Italy.
  • Fondazione Toscana Gabriele Monasterio, Via Moruzzi 1, 56100 Pisa, Italy.

ORCID-Profile: Giancarlo Trimarchi, Fausto Pizzino, Alessio Lilli, Augusto Esposito, Stefano Dalmiani, Annamaria Mazzone, Sergio Berti, Umberto Paradossi

Zitieren

APA

Trimarchi, G., Pizzino, F., Lilli, A., De Caterina, A. R., Esposito, A., Dalmiani, S., Mazzone, A., Di Bella, G., Berti, S., & Paradossi, U. (2024). Advanced Lung Cancer Inflammation Index as Predictor of All-Cause Mortality in ST-Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention. Journal of Clinical Medicine, 13(20), 6059. https://doi.org/10.3390/jcm13206059

Vancouver

Trimarchi G, Pizzino F, Lilli A, De Caterina AR, Esposito A, Dalmiani S, et al. Advanced Lung Cancer Inflammation Index as Predictor of All-Cause Mortality in ST-Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention. Journal of Clinical Medicine. 2024;13(20):6059. doi:10.3390/jcm13206059

BibTeX
@article{Trimarchi2024,
  author = {Trimarchi, Giancarlo and Pizzino, Fausto and Lilli, Alessio and De Caterina, Alberto Ranieri and Esposito, Augusto and Dalmiani, Stefano and Mazzone, Annamaria and Di Bella, Gianluca and Berti, Sergio and Paradossi, Umberto},
  title = {Advanced Lung Cancer Inflammation Index as Predictor of All-Cause Mortality in ST-Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention},
  journal = {Journal of Clinical Medicine},
  year = {2024},
  volume = {13},
  number = {20},
  pages = {6059},
  doi = {10.3390/jcm13206059}
}
Kostenlos starten →